PHAXIAM Therapeutics S.A. Increase Decrease Through Obtaining Or Losing Control Of Subsidiaries Or Other Businesses Liabilities Arising From Financing Activities

PHAXIAM Therapeutics S.A. Increase Decrease Through Obtaining Or Losing Control Of Subsidiaries Or Other Businesses Liabilities Arising From Financing Activities

PHAXIAM Therapeutics S.A. reported Increase Decrease Through Obtaining Or Losing Control Of Subsidiaries Or Other Businesses Liabilities Arising From Financing Activities of EUR 2.92 million for the 6-month period ending 2023-06-30, per its 6-K filed 2023-09-26.

Discontinued › Cash Flow › Operating Activities

ifrs-full:IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities · last filed 2023-09-26

• 2023-06-30: Increase Decrease Through Obtaining Or Losing Control Of Subsidiaries Or Other Businesses Liabilities Arising From Financing Activities 6 month 2.92M EUR.